Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Evolving Treatment Paradigms for Oropharyngeal Squamous Cell Carcinoma.

Cleary RK, Cmelak AJ.

J Glob Oncol. 2018 Sep;4:1-9. doi: 10.1200/JGO.2016.006304. Epub 2016 Nov 9.

2.

NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.

Colevas AD, Yom SS, Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Eisele DW, Fenton M, Foote RL, Gilbert J, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2018 May;16(5):479-490. doi: 10.6004/jnccn.2018.0026.

PMID:
29752322
3.

A simple technique to improve calculated skin dose accuracy in a commercial treatment planning system.

Wang L, Cmelak AJ, Ding GX.

J Appl Clin Med Phys. 2018 Mar;19(2):191-197. doi: 10.1002/acm2.12275. Epub 2018 Feb 6.

4.

Long-term Outcomes after Salvage Stereotactic Radiosurgery (SRS) following In-Field Failure of Initial SRS for Brain Metastases.

Rana N, Pendyala P, Cleary RK, Luo G, Zhao Z, Chambless LB, Cmelak AJ, Attia A, Stavas MJ.

Front Oncol. 2017 Nov 23;7:279. doi: 10.3389/fonc.2017.00279. eCollection 2017.

5.

Postoperative Fractionated Stereotactic Radiosurgery to the Tumor Bed for Surgically Resected Brain Metastases.

Cleary RK, Meshman J, Dewan M, Du L, Cmelak AJ, Luo G, Morales-Paliza M, Weaver K, Thompson R, Chambless LB, Attia A.

Cureus. 2017 May 26;9(5):e1279. doi: 10.7759/cureus.1279.

6.

NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.

Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Gilbert J, Haddad RI, Hicks WL Jr, Hitchcock YJ, Jimeno A, Leizman D, Lydiatt WM, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2017 Jun;15(6):761-770. doi: 10.6004/jnccn.2017.0101.

PMID:
28596256
7.

A phase I trial of concurrent sorafenib and stereotactic radiosurgery for patients with brain metastases.

Arneson K, Mondschein J, Stavas M, Cmelak AJ, Attia A, Horn L, Niermann K, Puzanov I, Chakravarthy AB, Xia F.

J Neurooncol. 2017 Jun;133(2):435-442. doi: 10.1007/s11060-017-2455-3. Epub 2017 May 9.

PMID:
28488066
8.

Purpose of Induction Chemotherapy in E1308 and Importance of Patient-Reported Outcomes in Deintensification Trials.

Marur S, Cmelak AJ, Burtness B.

J Clin Oncol. 2017 Jun 10;35(17):1968-1969. doi: 10.1200/JCO.2017.72.2918. Epub 2017 Apr 21. No abstract available.

PMID:
28430529
9.

A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer.

Vlacich G, Stavas MJ, Pendyala P, Chen SC, Shyr Y, Cmelak AJ.

Radiat Oncol. 2017 Jan 13;12(1):13. doi: 10.1186/s13014-016-0756-x.

10.

E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.

Marur S, Li S, Cmelak AJ, Gillison ML, Zhao WJ, Ferris RL, Westra WH, Gilbert J, Bauman JE, Wagner LI, Trevarthen DR, Balkrishna J, Murphy BA, Agrawal N, Colevas AD, Chung CH, Burtness B.

J Clin Oncol. 2017 Feb 10;35(5):490-497. doi: 10.1200/JCO.2016.68.3300. Epub 2016 Dec 28.

11.

Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234).

Divi V, Harris J, Harari PM, Cooper JS, McHugh J, Bell D, Sturgis EM, Cmelak AJ, Suntharalingam M, Raben D, Kim H, Spencer SA, Laramore GE, Trotti A, Foote RL, Schultz C, Thorstad WL, Zhang QE, Le QT, Holsinger FC.

Cancer. 2016 Nov 15;122(22):3464-3471. doi: 10.1002/cncr.30204. Epub 2016 Jul 15.

12.

Internal Lymphedema Correlates with Subjective and Objective Measures of Dysphagia in Head and Neck Cancer Patients.

Jackson LK, Ridner SH, Deng J, Bartow C, Mannion K, Niermann K, Gilbert J, Dietrich MS, Cmelak AJ, Murphy BA.

J Palliat Med. 2016 Sep;19(9):949-56. doi: 10.1089/jpm.2016.0018. Epub 2016 May 26.

13.

Initial radiographic tumor control is similar following single or multi-fractionated stereotactic radiosurgery for jugular paragangliomas.

Schuster D, Sweeney AD, Stavas MJ, Tawfik KY, Attia A, Cmelak AJ, Wanna GB.

Am J Otolaryngol. 2016 May-Jun;37(3):255-8. doi: 10.1016/j.amjoto.2016.01.002. Epub 2016 Feb 2.

PMID:
27178519
14.

Head and Neck Cancers, Version 1.2015.

Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Foote RL, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian N, Hughes M.

J Natl Compr Canc Netw. 2015 Jul;13(7):847-55; quiz 856.

15.

Long-term results of radiation therapy oncology group 9903: a randomized phase 3 trial to assess the effect of erythropoietin on local-regional control in anemic patients treated with radiation therapy for squamous cell carcinoma of the head and neck.

Shenouda G, Zhang Q, Ang KK, Machtay M, Parliament MB, Hershock D, Suntharalingam M, Lin A, Rotman M, Nabid A, Hong S, Shehata S, Cmelak AJ, Sultanem K, Le QT.

Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):907-15. doi: 10.1016/j.ijrobp.2014.12.018. Epub 2015 Feb 7.

16.

Short course high dose radiotherapy in the treatment of anaplastic thyroid carcinoma.

Stavas MJ, Shinohara ET, Attia A, Ning MS, Friedman JM, Cmelak AJ.

J Thyroid Res. 2014;2014:764281. doi: 10.1155/2014/764281. Epub 2014 Oct 14.

17.

Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology.

Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Schuller DE, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2014 Oct;12(10):1454-87.

18.

Clinical and scientific impact of human papillomavirus on head and neck cancer.

Friedman JM, Stavas MJ, Cmelak AJ.

World J Clin Oncol. 2014 Oct 10;5(4):781-91. doi: 10.5306/wjco.v5.i4.781. Review.

19.

Dose to the inferior pharyngeal constrictor predicts prolonged gastrostomy tube dependence with concurrent intensity-modulated radiation therapy and chemotherapy for locally-advanced head and neck cancer.

Vlacich G, Spratt DE, Diaz R, Phillips JG, Crass J, Li CI, Shyr Y, Cmelak AJ.

Radiother Oncol. 2014 Mar;110(3):435-40. doi: 10.1016/j.radonc.2013.12.007. Epub 2014 Jan 16.

PMID:
24440043
20.

Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines.

Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2013 Aug;11(8):917-23. Erratum in: J Natl Compr Canc Netw. 2013 Dec 1;11(12):1458.

PMID:
23946171
21.

Locally advanced head and neck cancer.

Cmelak AJ, Arneson K, Chau NG, Gilbert RW, Haddad RI.

Am Soc Clin Oncol Educ Book. 2013:237-44. doi: 10.1200/EdBook_AM.2013.33.237. Review.

22.

Impact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status, and quality of life.

Deng J, Murphy BA, Dietrich MS, Wells N, Wallston KA, Sinard RJ, Cmelak AJ, Gilbert J, Ridner SH.

Head Neck. 2013 Jul;35(7):1026-35. doi: 10.1002/hed.23084. Epub 2012 Jul 12.

23.

Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck.

Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Lustig R, Ensley JF, Thorstad W, Schultz CJ, Yom SS, Ang KK.

Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1198-205. doi: 10.1016/j.ijrobp.2012.05.008. Epub 2012 Jun 30.

24.

Factors associated with external and internal lymphedema in patients with head-and-neck cancer.

Deng J, Ridner SH, Dietrich MS, Wells N, Wallston KA, Sinard RJ, Cmelak AJ, Murphy BA.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):e319-28. doi: 10.1016/j.ijrobp.2012.04.013. Epub 2012 May 30.

PMID:
22652102
25.

Current issues in combined modality therapy in locally advanced head and neck cancer.

Cmelak AJ.

Crit Rev Oncol Hematol. 2012 Nov;84(2):261-73. doi: 10.1016/j.critrevonc.2012.04.004. Epub 2012 May 16. Review.

PMID:
22595517
26.

Intensity-modulated radiation therapy with concurrent carboplatin and paclitaxel for locally advanced head and neck cancer: toxicities and efficacy.

Vlacich G, Diaz R, Thorpe SW, Murphy BA, Kirby W, Sinard RJ, Shakhtour B, Shyr Y, Murphy P, Netterville JL, Yarbrough WG, Cmelak AJ.

Oncologist. 2012;17(5):673-81. doi: 10.1634/theoncologist.2011-0396. Epub 2012 May 1.

27.

Mucosal melanoma of the head and neck.

Pfister DG, Ang KK, Brizel DM, Burtness B, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Sanguineti G, Schuller DE, Shah JP, Spencer S, Trotti A 3rd, Weber RS, Wolf G, Worden F; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2012 Mar;10(3):320-38. No abstract available.

PMID:
22393194
28.

Prevalence of secondary lymphedema in patients with head and neck cancer.

Deng J, Ridner SH, Dietrich MS, Wells N, Wallston KA, Sinard RJ, Cmelak AJ, Murphy BA.

J Pain Symptom Manage. 2012 Feb;43(2):244-52. doi: 10.1016/j.jpainsymman.2011.03.019. Epub 2011 Jul 30.

PMID:
21802897
29.

Head and neck cancers.

Pfister DG, Ang KK, Brizel DM, Burtness BA, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Sanguineti G, Schuller DE, Shah JP, Spencer S, Trotti A 3rd, Weber RS, Wolf GT, Worden F; National Comprehensive Concer Network.

J Natl Compr Canc Netw. 2011 Jun 1;9(6):596-650. Review. No abstract available. Erratum in: J Natl Compr Canc Netw. 2011 Jul;9(7):xxxiii.

PMID:
21636536
30.

Synovial sarcoma of the head and neck: a review of its diagnosis and management and a report of a rare case of orbital involvement.

Kusuma S, Skarupa DJ, Ely KA, Cmelak AJ, Burkey BB.

Ear Nose Throat J. 2010 Jun;89(6):280-3. Review.

PMID:
20556741
31.

Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer.

Diaz R, Jaboin JJ, Morales-Paliza M, Koehler E, Phillips JG, Stinson S, Gilbert J, Chung CH, Murphy BA, Yarbrough WG, Murphy PB, Shyr Y, Cmelak AJ.

Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):468-76. doi: 10.1016/j.ijrobp.2009.05.018. Epub 2009 Jul 4.

PMID:
19577867
32.

Refractory lympho-epithelial carcinoma of the nasopharynx: a case report illustrating a protracted clinical course.

Wu FY, Yang ES, Willey CD, Ely K, Garrett G, Cmelak AJ.

Head Neck Oncol. 2009 Jun 15;1:18. doi: 10.1186/1758-3284-1-18.

33.

Management of infusion reactions in clinical trials and beyond: the US and EU perspectives.

Cmelak AJ, Lordick F, Borner M, Goldberg RM, Saif MW.

Oncology (Williston Park). 2009 Feb;23(2 Suppl 1):18-25. Review.

34.

Infusion reactions associated with monoclonal antibodies in patients with solid tumors. Introduction.

Cmelak AJ, Goldberg RM.

Oncology (Williston Park). 2009 Feb;23(2 Suppl 1):5-6. No abstract available.

35.

Thyroid storm after intensity-modulated radiation therapy: a case report and discussion.

Diaz R, Blakey MD, Murphy PB, Cryar AK, Cmelak AJ.

Oncologist. 2009 Mar;14(3):233-9. doi: 10.1634/theoncologist.2008-0156. Epub 2009 Mar 13.

36.

Evolution of clinical trials in head and neck cancer.

Yang ES, Murphy BM, Chung CH, Netterville JL, Burkey BB, Gilbert J, Yarbrough WG, Sinard R, Cmelak AJ.

Crit Rev Oncol Hematol. 2009 Jul;71(1):29-42. doi: 10.1016/j.critrevonc.2008.09.015. Epub 2008 Nov 7. Review.

PMID:
18996026
37.

Head and neck cancers.

National Comprehensive Cancer Network, Forastiere AA, Ang KK, Brizel D, Brockstein BE, Burtness BA, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Goepfert H, Hicks WL Jr, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pfister DG, Pinto HA, Posner MR, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Trotti A 3rd, Weber RS, Wolf GT, Worden F.

J Natl Compr Canc Netw. 2008 Aug;6(7):646-95. No abstract available.

PMID:
18691457
38.

Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399.

Cmelak AJ, Li S, Goldwasser MA, Murphy B, Cannon M, Pinto H, Rosenthal DI, Gillison M, Forastiere AA.

J Clin Oncol. 2007 Sep 1;25(25):3971-7.

PMID:
17761982
39.

Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03).

Machtay M, Pajak TF, Suntharalingam M, Shenouda G, Hershock D, Stripp DC, Cmelak AJ, Schulsinger A, Fu KK; Radiation Therapy Oncology Group.

Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1008-17. Epub 2007 Aug 23.

PMID:
17716826
40.

A Phase II multi-institutional trial of chemoradiation using weekly docetaxel and erythropoietin for high-risk postoperative head and neck cancer patients.

Willey CD, Murphy BA, Netterville JL, Burkey BB, Shyr Y, Shakhtour B, Kish B, Raben D, Chen C, Song JI, Kane MA, Cmelak AJ.

Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1323-31. Epub 2007 Feb 7.

PMID:
17289289
41.

Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: results of a phase II multi-institutional trial.

Cmelak AJ, Murphy BA, Burkey B, Douglas S, Shyr Y, Netterville J.

Head Neck. 2007 Apr;29(4):315-24.

PMID:
17252600
42.

Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.

Chung CH, Parker JS, Ely K, Carter J, Yi Y, Murphy BA, Ang KK, El-Naggar AK, Zanation AM, Cmelak AJ, Levy S, Slebos RJ, Yarbrough WG.

Cancer Res. 2006 Aug 15;66(16):8210-8.

43.

Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma.

Slebos RJ, Yi Y, Ely K, Carter J, Evjen A, Zhang X, Shyr Y, Murphy BM, Cmelak AJ, Burkey BB, Netterville JL, Levy S, Yarbrough WG, Chung CH.

Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):701-9.

44.

The efficacy of linear accelerator radiosurgery in the management of patients with Cushing's disease.

Devin JK, Allen GS, Cmelak AJ, Duggan DM, Blevins LS.

Stereotact Funct Neurosurg. 2004;82(5-6):254-62. Epub 2005 Jan 20.

PMID:
15665560
45.

Phantom validation of coregistration of PET and CT for image-guided radiotherapy.

Lavely WC, Scarfone C, Cevikalp H, Li R, Byrne DW, Cmelak AJ, Dawant B, Price RR, Hallahan DE, Fitzpatrick JM.

Med Phys. 2004 May;31(5):1083-92.

PMID:
15191296
46.

Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.

Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Machtay M, Ensley JF, Chao KS, Schultz CJ, Lee N, Fu KK; Radiation Therapy Oncology Group 9501/Intergroup.

N Engl J Med. 2004 May 6;350(19):1937-44.

47.

Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.

Scarfone C, Lavely WC, Cmelak AJ, Delbeke D, Martin WH, Billheimer D, Hallahan DE.

J Nucl Med. 2004 Apr;45(4):543-52.

48.

The utility of external beam radiation and intracystic 32P radiation in the treatment of craniopharyngiomas.

Schefter JK, Allen G, Cmelak AJ, Johnson M, Toms S, Duggan D, Blevins LS.

J Neurooncol. 2002 Jan;56(1):69-78.

PMID:
11949829

Supplemental Content

Loading ...
Support Center